Abstract
Occult visceral arterio-venous malformations (AVMs) may be a constant threat to patients suffering from hereditary hemorrhagic telangiectasia (HHT), also known as Rendu-Osler-Weber syndrome (M. ROW). HHT patients predominantly become symptomatic through chronic, recurrent epistaxis, a symptom that can alert physicians at an early stage of the disease. The purpose of this study was to investigate whether occult, visceral arterio-venous malformations could be detected by screening imaging studies in patients suffering from HHT. In a comprehensive diagnostic study, Rendu-Osler-Weber patients were examined for potential visceral arterio-venous malformations by physical examination and non-invasive imaging techniques. The Department of Otolaryngology of the Philipps University of Marburg is a major referral center and coordinated the screening procedures. Thirty-five individuals with the presumed diagnosis of HHT gave informed consent to the screening investigations. Eighteen of 35 individuals were found to suffer from visceral vascular malformations; most of the AVMs were diagnosed in the lung, but also the liver, spleen, brain and eyes were affected. Six patients could be treated preventively by arterial embolization for AVMs of the lung, liver and brain. Comprehensive screening for occult AVMs in HHT patients seems to be justified to avert potential complications in this group of patients.
Similar content being viewed by others
References
AAssar OS, Friedman CM, White RI Jr (1991) The natural history of epistaxis in hereditary hemorrhagic telangiectasia. Laryngoscope 101:977–980
Lund VJ, Howard DJ (1999) A treatment algorithm for the management of epistaxis in hereditary hemorrhagic telangiectasia. Am J Rhinol 13:319–322
Shovlin CL, Guttmacher AE, Buscarini E, Faughnan ME, Hyland RH, Westermann CJJ, et al (2000) Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome). Am J Med Genet 91:66–67
Porteous MEM, Burn J, Proctor SJ (1992) Hereditary haemorrhagic telangiectasia: a clinical analysis. J Med Genet 29:527–530
Shovlin CL, Hughes JM, Tuddenham EG, Temperley I, Perembelon YF, Scott J et al (1994) A gene for hereditary haemorrhagic telangiectasia maps to chromosome 9q3. Nat Genet 6:205–209
McAllister KA, Grogg KM, Johnson DW, Gallione CJ, Baldwin MA, Jackson CE, et al (1994) Endoglin, a TGF-ß binding protein of endothelial cells, is the gene of hereditary hemorrhagic telangiectasia type 1. Nat Genet 8:345–351
Vincent P, Plauchu H, Hazan J, Faure S, Weissenbach J, Godet J (1995) A third locus for hereditary haemorrhagic telangiectasia maps to chromosome 12q. Hum Mol Genet 4:945–949
Johnson DW, Berg JN, Baldwin MA, Gallione CJ, Marondel I, Yoon SJ, et al (1996) Mutations in the activin receptor-like kinase 1 gene in hereditary hemorrhagic telangiectasia type 2. Nat Genet 13:189–195
Piantanida M, Buscarini E, Dellavecchia C, Minelli A, Rossi A, Buscarini L, et al (1996) Hereditary haemorrhagic telangiectasia with extensive liver involvement is not caused by either HHT1 or HHT2. J Med Genet 33:441–443
Plauchu H, Bideau A (1984) Épidémiologie et constitution d’un registre de population à propos d’ une concentration géographique d’une maladie héréditaire rare. Population 4:765–786
Pasche B, Cerra Wollstein A, Zoll B, Folz B (2003) Rendu-Osler-Weber-Syndrom. Dtsch Arztebl 100:A490–493
Vase P, Holm M, Arendrup H (1985) Pulmonary arteriovenous fistulas in hereditary hemorrhagic telangiectasia. Acta Med Scand 218:105–109
Teragaki M, Akioka K, Yasuda M, Ikuno Y, Oku H, Takeuchi K, Takeda T (1988) Hereditary hemorrhagic telangiectasias with growing arteriovenous fistulas followed for 24 years. Am J Med Sci 295:545–547
Plauchu H, de Chadarevian JP, Bideau A, Robert JM (1989) Age-related clinical profile of hereditary hemorrhagic telangiectasia in an epidemiologically recruited population. Am J Med Genet 32:291–297
Kjeldsen AD, Oxhoj H, Andersen PE, Elle B, Jacopsen JP, Vase P (1999) Pulmonary arteriovenous malformations. Screening procedures and pulmonary angiography in patients with hereditary haemorrhagic telangiectasia. Chest 116:432–440
Stecker RH, Lake CF (1965) Hereditary hemorrhagic telangiectasia. Arch Otolaryngol 82:522–526
Werner JA, Lippert BM, Geisthoff UW, Rudert H (1997) Nd:YAG-Lasertherapie der rezidivierenden Epistaxis bei hereditärer hämorrhagischer Teleangiektasie. Laryngorhinootologie 76:495–501
Bergler W, Riedel F, Baker-Schreyer A, Juncker C, Hörmann K (1999) Argon plasma coagulation for the treatment of hereditary hemorrhagic telangiectasia. Laryngoscope 109:15–20
Werner JA (1999) Behandlungskonzept der rezidivierenden Epistaxis bei Patienten mit hereditärer hämorhagischer Telangiektasie. HNO 47:525–529
Werner JA, Geisthoff UW, Lippert BM, Rudert H (1997) Behandlung der rezidivierenden Epistaxis beim Morbus Rendu-Osler-Weber. HNO 9:673–681
Shovlin CL, Winstock AR, Peters AM, Jackson JE, Hughes JM (1995) Medical complications of pregnancy in hereditary haemorrhagic telangiectasia. QJM 88:879–887
Laroche CM, Wells F, Shneerson J (1992) Massive hemothorax due to enlarging arteriovenous fistula in pregnancy. Chest 101:452–454
Ference BA, Shannon TM, White RI, Zavin M, Burdge CM (1994) Life-threatening pulmonary hemorrhage with pulmonary arteriovenous malformations and hereditary hemorrhagic telangiectasia. Chest 106:1387–1390
Mohler ER, Monahan B, Canty MD, Flockhart DA (1991) Cerebral abscess associated with dental procedure in hereditary haemorrhagic telangiectasia. Lancet 338:508–509
Kjeldsen AD, Oxhoj H, Andersen PE, Green A, Vase P (2000) Prevalence of pulmonary arteriovenous malformations (PAVMs) and occurrence of neurological symptoms in patients with hereditary hemorrhagic telangiectasia (HHT). J Intern Med 248:255–262
Maher CO, Piepgras DG, Brown RD, Friedman JA, Pollock BE (2001) Cerebrovascular manifestations in 321 cases of hereditary hemorrhagic telangiectasia. Stroke 32:877–882
Remy J, Remy-Jardin M, Wattinne L, Deffontaines C (1992) Pulmonary arteriovenous malformations: evaluation with CT of the chest before and after treatment. Radiology 182:809–816
Faughnan ME, Hyland RH, Nanthakumar K, Redelmeier DA (2000) Screening in hereditary hemorrhagic telangiectasia patients. Chest 118:566–567
Terry PB, Barth KH, Kaufman SL, White RI (1980) Balloon embolization for treatmentof pulmonary arteriovenous fistulas. N Engl J Med 302:1189–1190
White RI (1996) Pulmonary arteriovenous malformations and hereditary hemorrhagic telangiectasia: embolotherapie using balloons and coils. Arch Intern Med 9:2627–2628
White RI Jr, Lynch-Nyhan A, Terry P, Buescher PC, Farmlett EJ, Charnas L, et al (1988) Pulmonary arteriovenous malformations: techniques and long-term outcome of embolotherapy. Radiology 169:663–669
Cloogman HM, DiCapo RD (1984) Hereditary hemorrhagic telangiectasia: sonographic findings in the liver. Radiology :521–522
Caselitz M, Chavan A, Manns MP, Wagner S (2001) Die Hereditäre Hämorrhagische Telangiektasie (Morbus Osler-Rendu-Weber) und ihre Manifestation an der Leber. Z Gastroenterol 39:533–542
Derauf BJ, Hunter DW, Sirr SA, Cardella JF, Castaneda-Zuniga W, Amplatz K (1987) Peripheral embolization of diffuse hepatic arteriovenous malformations in a patient with hereditary hemorrhagic telangiectasia. Cardiovasc Intervent Radiol 10:80–83
Whiting JH, Korzenic JR, Miller FJ, Pollack JS, White RI (2000) Fatal outcome after embolotherapy for hepatic arteriovenous malformations of the liver in two patients with hereditary hemorrhagic telangectasia. J Vasc Interv Radiol 11:855–858
Pfitzmann R, Heise M, Langrehr JM, Jonas S, Steinmuller T, Podrabsky P, et al (2001) Liver transplantation for treatment of intrahepatic Osler’s disease: first experiences. Transplantation 72:237–241
Uhlenbrock D, Antoni D, Kukulies R (1985) Nuclear medicine and X-ray findings in Osler’s disease of the lung. Nuklearmedizin 24:52–54
Lewis BS, Swain P (2002) Capsule endoscopy in the evaluation of patients with suspected small intestinal bleeding: results of a pilot study. Gastrointest Endosc 56:349–353
Haitjema T, Disch F, Overtoom TT, Westermann CJ, Lammers JW (1995) Screening family members of patients with hereditary hemorrhagic telangiectasia. Am J Med 99:519–524
Matsubara S, Manzia JL, Brugge K, Willinsky RA, Montanera W, Faughnan ME (2000) Angiographic and clinical characteristics of patients with cerebral arteriovenous malformations associated with hereditary hemorrhagic telangiectasia. Am J Neuroradiol 21:1016–1020
Mandzia J, Henderson K, Faughnan M, White R Jr (2001) Compelling reasons to screen brain in HHT. Stroke 32:2957–2958
Garcia-Monaco R, Taylor W, Rodesch G, Alvarez H, Burrows P, Coubes P, Lasjaunias P (1995) Pial arteriovenous fistula in children as presenting manifestation of Rendu-Osler-Weber disease. Neuroradiology 37:60–64
Ziani M, Valignat C, Lopez JG, Ruffion A, Plauchu H, Perrin P (2000) Renal arteriovenous malformation requiring surgery in Rendu-Osler-Weber disease (hereditary hemorrhagic telangiectasia). J Urol 164:1292–1293
Gurevitch Y, Hasin Y, Gotsman MS, Rozenman Y (1998) Coronary arteriovenous malformations in a patient with hereditary hemorrhagic telangiectasia—a case report. Angiology 49:577–580
Vase I, Vase P (1979) Ocular lesions in hereditary haemorrhagic telangiectasia. Acta Ophthalmol 57:1084–1090
Beech R, Rudd AG, Tilling K, Wolfe CD (1999) Economic consequences of early inpatient discharge to community-based rehabilitation for stroke in an inner-London teaching hospital. Stroke 30:729–735
Acknowledgements
The authors would like to acknowledge the help of N. Sapundzhiev for data processing and technical help with image processing.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Folz, B.J., Wollstein, A.C., Alfke, H. et al. The value of screening for multiple arterio-venous malformations in hereditary hemorrhagic telangiectasia: a diagnostic study. Eur Arch Otorhinolaryngol 261, 509–516 (2004). https://doi.org/10.1007/s00405-003-0719-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00405-003-0719-3